Search results
Author(s):
Oussama M Wazni
,
Allan L Klein
Added:
3 years ago
Atrial fibrillation (AF) is the most commonly sustained arrhythmia with a prevalence of 0.4% in the general population1-4 affecting 2.3 million people in the US.5 The prevalence increases with age being <1% in persons younger than 60 years of age to >8% in those older than 80 years.1,5-8 The incidence ranges from 0.2% per year for men 30 to 39 years of age to 2.3% per year in men 80 to 89…
View more
Author(s):
Mark Huffman
,
Vallerie V McLaughlin
Added:
3 years ago
Idiopathic pulmonary arterial hypertension (formerly referred to as primary pulmonary hypertension) is an uncommon yet progressively fatal disease defined by the presence of mean pulmonary artery pressure greater than 25mmHg at rest or greater than 30mmHg with exercise as tested by right heart catheterization in the absence of other etiologies for pulmonary hypertension. Across several studied…
View more
Author(s):
Mark Huffman
,
Vallerie V McLaughlin
Added:
3 years ago
Idiopathic pulmonary arterial hypertension (formerly referred to as primary pulmonary hypertension) is an uncommon yet progressively fatal disease defined by the presence of mean pulmonary artery pressure greater than 25mmHg at rest or greater than 30mmHg with exercise as tested by right heart catheterization in the absence of other etiologies for pulmonary hypertension. Across several studied…
View more
Author(s):
Sascha Ott
,
Laura Leser
,
Pia Lanmüller
,
et al
Added:
2 years ago
Author(s):
Kari Gorder
,
Steve Rudick
,
Timothy D Smith
Added:
2 years ago
Author(s):
JM Prutkin
,
MA Chen
,
RW Rho
,
et al
Added:
3 years ago
Numerous clinical trials involving patients with severe, symptomatic heart failure and a wide QRS complex have shown benefits from cardiac resynchronization therapy (CRT). CRT can increase left ventricular ejection fraction (LVEF), decrease LV volume and mitral regurgitation, improve symptoms caused by heart failure,1-3 and may also improve mortality.4,5 Current American College of Cardiology/…
View more
Author(s):
JM Prutkin
,
MA Chen
,
RW Rho
,
et al
Added:
3 years ago
Numerous clinical trials involving patients with severe, symptomatic heart failure and a wide QRS complex have shown benefits from cardiac resynchronization therapy (CRT). CRT can increase left ventricular ejection fraction (LVEF), decrease LV volume and mitral regurgitation, improve symptoms caused by heart failure,1-3 and may also improve mortality.4,5 Current American College of Cardiology/…
View more
Author(s):
Alexander G Truesdell
,
Rhian E Davies
,
Moemen Eltelbany
,
et al
Added:
11 months ago
Author(s):
Giuseppe Rosano
,
Harriette Van Spall
Added:
5 months ago
ESC 23 – Late-Breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Giuseppe Rosano (St George’s Hospitals NHS Trust University of London, UK), President of HFA to distil the key messages from the 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.
Prof Rosano summarises the retained ejection fraction…
View more
Author(s):
Rebecca L Attridge
,
Rebecca D Moote
,
Deborah J Levine
Added:
3 years ago
Pulmonary hypertension is classified into five groups by the World Health Organization (WHO). Group 1, pulmonary arterial hypertension (PAH), is a progressive disease characterized by an elevation in pulmonary arterial pressure and pulmonary vascular resistance that may progress to right heart dysfunction and failure.1 PAH is defined as a mean pulmonary artery pressure (mPAP) ≥25 mmHg at rest,…
View more